Frank Schulkes Purchases 65,000 Shares of ConvaTec Group PLC (CTEC) Stock

Share on StockTwits

ConvaTec Group PLC (LON:CTEC) insider Frank Schulkes acquired 65,000 shares of the business’s stock in a transaction on Monday, October 15th. The stock was acquired at an average price of GBX 150 ($1.96) per share, for a total transaction of £97,500 ($127,401.02).

LON:CTEC opened at GBX 150.60 ($1.97) on Friday. ConvaTec Group PLC has a 52 week low of GBX 181.40 ($2.37) and a 52 week high of GBX 349.10 ($4.56).

The company also recently declared a dividend, which was paid on Friday, October 12th. Stockholders of record on Thursday, September 6th were issued a dividend of GBX 1.31 ($0.02) per share. This is a boost from ConvaTec Group’s previous dividend of $0.04. The ex-dividend date of this dividend was Thursday, September 6th. This represents a dividend yield of 0.58%.

CTEC has been the topic of a number of recent research reports. Deutsche Bank restated a “sell” rating on shares of ConvaTec Group in a report on Friday, October 5th. Royal Bank of Canada restated an “outperform” rating and issued a GBX 240 ($3.14) price objective on shares of ConvaTec Group in a report on Wednesday, August 8th. JPMorgan Chase & Co. cut shares of ConvaTec Group to a “neutral” rating and cut their price objective for the stock from GBX 280 ($3.66) to GBX 183 ($2.39) in a report on Tuesday. Peel Hunt restated a “hold” rating on shares of ConvaTec Group in a report on Tuesday, September 4th. Finally, Numis Securities restated a “hold” rating and issued a GBX 220 ($2.87) price objective on shares of ConvaTec Group in a report on Monday. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. ConvaTec Group currently has an average rating of “Hold” and a consensus target price of GBX 216.78 ($2.83).

ConvaTec Group Company Profile

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.

Featured Article: Cash Flow

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply